Market Opportunity : Major opportunities include oral GLP-1 innovations, combination therapies integrating GIP/GLP-1 pathways, improved affordability for emerging markets, expanding indications beyond diabetes and obesity, and partnerships to enhance manufacturing capacity, distribution, and long-term patient adherence
Some telehealth outfits have signaled their intention to continue offering their products.Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs, Andrew Dudum, founder and CEO of Hims & Hers Health, wrote on X, adding that the company is closely monitoring potential future shortages
When Epithalon was presented in these otherwise aging cells, it appeared to stimulate the development of telomeres, causing them to increase and restore their normal size
Weight regain in their study was linked with anxiety, anemia, thyroid hormone changes during treatment that remained within the bounds of normal, and depression and antibiotic prescriptions after discontinuation
14,15 It is helpful to first ask permission to discuss weight, review past experiences with weight management, and use person-first language to emphasize that people are not defined by their condition (e.g., a patient has or lives with diabetes or obesity, rather than a diabetic or obese patient)
